Others

Strides Pharma Science Ltd - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

| Updated on July 29, 2019 Published on July 29, 2019

The Board of Directors of the Company in its meeting held today have approved the Scheme of Amalgamation (Scheme) for merger of Arrow Remedies Private Limited (Arrow Remedies), Fagris Medica Private Limited (Fagris Medica) and Strides Emerging Markets Limited (SEML) with the Company, pursuant to Sections 230 to 232 of the Companies Act, 2013. Arrow Remedies, Fagris Medica and SEML are, direct or indirect, wholly-owned subsidiaries of the Company.

The Scheme is subject to necessary statutory and regulatory approvals including the approvals of National Company Law Tribunal, the shareholders and creditors of each of the companies.

The disclosures required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with relevant circulars is enclosed as Annexure A to this intimation.

Pdf Link: Strides Pharma Science Ltd - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

Source : BSE - www.bseindia.com

Published on July 29, 2019
This article is closed for comments.
Please Email the Editor